Details for New Drug Application (NDA): 084950
✉ Email this page to a colleague
NDA 084950 describes MENEST, which is a drug marketed by Monarch Pharms and is included in four NDAs. It is available from one supplier. Additional details are available on the MENEST profile page.
The generic ingredient in MENEST is estrogens, esterified. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, esterified profile page.
The generic ingredient in MENEST is estrogens, esterified. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, esterified profile page.
Summary for 084950
| Tradename: | MENEST |
| Applicant: | Monarch Pharms |
| Ingredient: | estrogens, esterified |
| Patents: | 0 |
Suppliers and Packaging for NDA: 084950
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MENEST | estrogens, esterified | TABLET;ORAL | 084950 | ANDA | Pfizer Laboratories Div Pfizer Inc | 61570-074 | 61570-074-01 | 100 TABLET, FILM COATED in 1 BOTTLE (61570-074-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1.25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
